Top Tweets for #practicechanging
🔥🚨@OncoAlert Hot off the press.
Just presented @ASCO #ASCO26 (#Plenary Presentation) by Dr. Jonathan Goldman.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
📣Results published simultaneously @NEJM (See tweet/post below👇🏻)
🔥🚨@OncoAlert Hot off the press.
Just published @NEJM In conjunction with presentation @ASCO #ASCO26.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
👇🏻
https://t.co/u6PLyTLCqr
🔥🚨@OncoAlert Hot off the press.
Just published @NEJM In conjunction with presentation @ASCO #ASCO26.
⭐️Results of #PracticeChanging #LIBRETTO432 Trial of:
#Adjuvant #Selpercatinib vs #Placebo
in Early-Stage (IB-IIIA) #RET+ Non-Small-Cell #LungCancer.
✅⬆️#EFS
❇️#HR: 0.17 for stage II-IIIA
2-year EFS: 92% vs 61%
❇️#HR: 0.16 for stage IB-IIIA
2-year EFS: 94% vs 70%
🎯‼️#NEW #StandardOfCare
👇🏻
https://t.co/u6PLyTLCqr
Our UChicago Post-ASH is just one week away!! There's still time to register at https://t.co/Ann6ISiogR
#ASH #PracticeChanging #CancerCare #CancerResearch
#VESALIUS-CV trial: in pts at high CV risk w/o a prior event, the addition of evolocumab to baseline LLRx showed a significant reduction in MACE!! CV death & all cause death were lower.. Results consistent across all sub-groups… #AHA2025 #LBCT #PracticeChanging @AHAScience
Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25 - Ruben Mesa
@mpdrc @EHA_Hematology @HarryGillHKUMed
https://t.co/jbQEqPl4ad
#Cancer #EssentialThrombocythemia #MedX #MedNews #MedEd #PracticeChanging #EHA25 #Medicine #Health #Oncology #OncoDaily
Honored to have been the senior author of this #PlenaryAbstract at #EHA25 (presented by great colleague @HarryGillHKUMed ) of the Phase III #Superiority of #ROPEG over #ANAGRELIDE in 2L for ET #PracticeChanging
@LevineCancer @wakeforestmed @AtriumHealth @PharmaEssentia
Amazing #PracticeChanging #ASCO25 results led by our own Dr Peter Voorhees @PlasmaCellPete , Associate Director of Clinical Research @AtriumHealthWFB Comprehensive Cancer Center @wakeforestmed @LevineCancer
After terminally ill patients tried a last-ditch blood cancer treatment, doctors are talking about a potential cure. https://t.co/LoXYqdc29F
Breakthroughs, buzz, bad coffee + the best people in oncology. ASCO, you never disappoint.
#ASCO25 #LatteGirl #CancerResearch #Oncology #ClinicalTrials #PracticeChanging #MedEd #WomenInMedicine #womeninoncology @ASCO
Amazing #PracticeChanging #ASCO25 results led by our own Dr Peter Voorhees @PlasmaCellPete , Associate Director of Clinical Research @AtriumHealthWFB Comprehensive Cancer Center @wakeforestmed @LevineCancer
A possible game-changer for those battling relapsed/refractory multiple myeloma (RRMM). 🩸Our study shows that 33% of patients treated with cilta-cel have remained progression-free for ≥5 years. #ASCO25 Link: https://t.co/MA1BE7CJDQ
Up next at LBA session at #ESTRO25 is @DrSineadBrennan presenting results of @IRROGTrials OPEN study based at St Luke’s Radiation Oncology Network
1st RCT in this area:
➡️ 3 point OPEN masks superior:
➡️ Improved patient experience
#PracticeChanging
#LateBreaking #STRIDE #PAD #DM2 #Simaglutide saw significant benefit in symptoms and #ABI 🔥🔥
#GLP1 drug again impressed with outcomes, Now in the field of PAD, regardless of their #BMI
#PracticeChanging ?? Thoughts??
#ACC25 @ACCinTouch 🫀
#ESOPEC - periop FLOT vs neoadjuvant CROSS in resectable ESO/GEJ adeno - publication out today! @NEJM
#practicechanging
@OncoAlert @OncEd
🔗 https://t.co/FxSdkexlyL
@juanpabloarab @AnandVKulkarni2 @AIGHospitals @AASLDtweets Hearty Congratulations Team!! #PracticeChanging
🚨🔥2/2 This #PracticeChanging results of #ADRIATIC trial showed:
✅ ⬆️ #mOS: 55.9 vs 33.4 months (HR 0.73)
✅ ⬆️ #mPFS: 16.6 vs 9.2 months (HR 0.76)
Was a pleasure to sit down with my good friend @Daniel_J_George and talk about a truly #practicechanging trial in #prostatecancer.
Novel hormonal therapies for high-risk biochemical recurrence: the #EMBARK trial. @SFreedlandMD @CSCancerCenter joins @Daniel_J_George @DukeCancer to discuss the EMBARK study and highlight its significant impact on metastasis-free survival. #WatchNow > https://t.co/0iF1KCnRGR
@NephJC From now on, I'll be like, "Here is your 2-yr and 5-yr risk for dialysis...but because you have a rare kidney disease it is worse."
#PracticeChanging
#NephJC
The #PV GOAT 🐐(or in French “Le Bouc”) Prof JJ Kiladjian @jjkiladjian sharing important data that JAK2-V617F molecular response correlates with event free survival! #PracticeChanging #EHA2024 @doctorpemm @harrisoncn1 #ROPEG #MPNSM
Last Seen Hashtags on Sotwe
jjknsfw
Seen from Spain
سکس_ایرانی
Seen from United States
zelal
Seen from Turkey
รับงานบางบัวทอง
Seen from Thailand
Fan
Seen from Brazil
التانجو
Seen from Spain
hoejabi
Seen from United Kingdom
ometv #omegle #monkeyapp
Seen from United Kingdom
小倉駅７番８番ホーム
Seen from Brazil
puppylove
Seen from Netherlands
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.5M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers